|
|
|
|
登录后可显示你上传的书籍、积分、金币等信息 |
|
|
|
|
Title:
Neurotransmitters and Neuromodulators: Handbook of Receptors and Biological Effects, 2nd, Completely Revised and Enlarge |
|
|
Division: General Biochemistry / John Wiley & Son / 英文版 |
Author/Editor: Oliver von Bohlen und Halbach, Rolf Dermietzel Star:  |
|
ISBN: 3527313079 |
|
Introduce Date: 2007年01月16日20:49 , Release Date: 2007年01月16日20:52 |
|
Introducer: Metalcarbene , Rate: 2/114 |
| Format: pdf(editorial) Download |
|
|
| Appraiser: choscar | Grade: +5 | Reason: ( New book! ) | |
|
|
|
|
| Description: |
Neurotransmitters and Neuromodulators: Handbook of Receptors and Biological Effects, 2nd, Completely Revised and Enlarged Edition
Oliver von Bohlen und Halbach, Rolf Dermietzel
ISBN: 978-3-527-31307-5
Hardcover
402 pages
November 2006
Wiley List Price: US $150.00
A complete update of the highly acclaimed handbook with data on all neurotransmitters and the majority of neuromodulators. The coverage is now even more comprehensive, with 15% more entries on neuropeptides, "classic" neurotransmitters and related substances in a clear, alphabetical format. The methodological section has been expanded by 50% and now includes color figures, plus new chapters on genomics, proteomics, databases, microarrays, MALDI-TOF, neutrophins, FGF, endocannabinoids and neuroimaging. The text provides clearly structured information on the biosynthesis and degradation, localization, receptors, signal transduction pathways, and biological effects in the central nervous system, with all substances uniformly treated for an easy comparison of data. Furthermore, introductory chapters on receptors, transporters, and the blood-brain barrier make this an indispensable tool for researchers, teachers, and advanced students, as well as a must-have for every neuroscientist.
Preface for the Second Edition.
Preface for the First Edition.
1 Introduction.
1.1 Neuroactive Substances.
1.1.1 Neurotransmitters.
1.1.2 Neuromodulators.
1.2 Receptors and Transporters.
1.2.1 Ionotropic Receptors.
1.2.2 Metabotropic Receptors.
1.2.3 Receptor Regulation.
1.2.4 Transporters.
1.3 Distribution and Localization of Neurotransmitters and Neuromodulators.
1.4 The Blood–Brain Barrier.
1.5 Volume Transmission and Wiring Transmission.
2 Methods.
2.1 Bio- and Radioisotope Assays.
2.2 Microdialysis and Electrochemical Detection.
2.2.1 Microdialysis.
2.2.2 Electrochemical Detection.
2.3 Chromatography.
2.3.1 Affinity Chromatography.
2.3.2 High Performance Liquid Chromatography.
2.3.3 Proteomics: Multidimensional Protein Identification Technology.
2.4 Autoradiography.
2.5 Immunohistochemical Methods.
2.6 In situ Hybridization.
2.7 Staining and Neuroanatomical Tract Tracing.
2.8 Electrophysiology.
2.8.1 In vivo Recording.
2.8.2 In vitro Recording.
2.9 Behavioral Testing.
2.9.1 Classic Conditioning.
2.9.2 Operant Conditioning.
2.9.3 Further Behavioral Tests.
3 Neurotransmitters.
3.1 Acetylcholine.
3.1.1 General Aspects and History.
3.1.2 Localization Within the Central Nervous System.
3.1.3 Biosynthesis and Degradation.
3.1.4 Receptors and Signal Transduction.
3.1.5 Biological Effects.
3.1.6 Neurological Disorders and Neurogenerative Diseases.
3.2 Dopamine.
3.2.1 General Aspects and History.
3.2.2 Differentiation and Localization of the Dopaminergic System.
3.2.3 Biosynthesis and Degradation.
3.2.4 Release, Re-uptake and Degradation.
3.2.5 Receptors and Signal Transduction.
3.2.6 Biological Effects.
3.2.7 Neurological Disorders and Neurodegenerative Diseases.
3.3 _-Amino Butyric Acid.
3.3.1 General Aspects and History.
3.3.2 Localization Within the Central Nervous System.
3.3.3 Biosynthesis and Degradation.
3.3.4 GABA Transporters.
3.3.5 Receptors and Signal Transduction.
3.3.6 Biological Effects.
3.3.7 Neurological Disorders and Neurogenerative Diseases.
3.4 Glutamate and Aspartate.
3.4.1 General Aspects and History.
3.4.2 Localization Within the Central Nervous System.
3.4.3 Biosynthesis and Degradation.
3.4.4 Transporters.
3.4.5 Receptors and Signal Transduction.
3.4.6 Biological Effects.
3.4.7 Neurological Disorders and Neurodegenerative Diseases.
3.5 Glycine.
3.5.1 General Aspects and History.
3.5.2 Localization Within the Central Nervous System.
3.5.3 Biosynthesis and Degradation.
3.5.4 Receptors and Signal Transduction.
3.5.5 Biological Effects.
3.5.6 Neurological Disorders and Neurodegenerative Diseases.
3.6 Histamine.
3.6.1 General Aspects and History.
3.6.2 Localization Within the Central Nervous System.
3.6.3 Biosynthesis and Degradation.
3.6.4 Receptors and Signal Transduction.
3.6.5 Biological Effects.
3.6.6 Neurological Disorders and Neurodegenerative Diseases.
3.7 Norepinephrine.
3.7.1 General Aspects and History.
3.7.2 Localization Within the Central Nervous System.
3.7.3 Biosynthesis and Degradation.
3.7.4 Receptors and Signal Transduction.
3.7.5 Biological Effects.
3.7.6 Neurological Disorders and Neurodegenerative Diseases.
3.8 Serotonin (5-Hydroxytryptamine).
3.8.1 General Aspects and History.
3.8.2 Localization Within the Central Nervous System.
3.8.3 Biosynthesis and Degradation.
3.8.4 Receptors and Signal Transduction.
3.8.5 Biological Effects.
3.8.6 Neurological Disorders and Neurodegenerative Diseases.
4 Neuromodulators.
4.1 Adrenocorticotropic Hormone.
4.1.1 General Aspects and History.
4.1.2 Localization Within the Central Nervous System.
4.1.3 Biosynthesis and Degradation.
4.1.4 Receptors and Signal Transduction.
4.1.5 Biological Effects.
4.1.6 Neurological Disorders and Neurodegenerative Diseases.
4.2 Anandamide (Endocannabinoids).
4.2.1 General Aspects and History.
4.2.2 Localization Within the Central Nervous System.
4.2.3 Biosynthesis and Degradation.
4.2.4 Receptors and Signal Transduction.
4.2.5 Biological Effects.
4.2.6 Neurological Disorders and Neurodegenerative Diseases.
4.3 Angiotensin.
4.3.1 General Aspects and History.
4.3.2 Localization Within the Central Nervous System.
4.3.3 Biosynthesis and Degradation.
4.3.4 Receptors and Signal Transduction.
4.3.5 Biological Effects.
4.3.6 Neurological Disorders and Neurodegenerative Diseases.
4.4 Atrial Natriuretic Factor.
4.4.1 General Aspects and History.
4.4.2 Localization Within the Central Nervous System.
4.4.3 Biosynthesis and Degradation.
4.4.4 Receptors and Signal Transduction.
4.4.5 Biological Effects.
4.4.6 Neurological Disorders and Neurodegenerative Diseases.
4.5 Bombesin and Related Neuropeptides.
4.5.1 General Aspects and History.
4.5.2 Localization Within the Central Nervous System.
4.5.3 Biosynthesis and Degradation.
4.5.4 Receptors and Signal Transduction.
4.5.5 Biological Effects.
4.6 Calcitonin and Calcitonin Gene-related Protein.
4.6.1 General Aspects and History.
4.6.2 Localization Within the Central Nervous System.
4.6.3 Biosynthesis and Degradation.
4.6.4 Receptors and Signal Transduction.
4.6.5 Biological Effects.
4.6.6 Neurological Disorders and Neurodegenerative Diseases.
4.7 Cholecystokinin.
4.7.1 General Aspects and History.
4.7.2 Localization Within the Central Nervous System.
4.7.3 Biosynthesis and Degradation.
4.7.4 Receptors and Signal Transduction.
4.7.5 Biological Effects.
4.7.6 Neurological Disorders and Neurodegenerative Diseases.
4.8 Corticotropin-releasing Factor.
4.8.1 General Aspects and History.
4.8.2 Localization Within the Central Nervous System.
4.8.3 Biosynthesis and Degradation.
4.8.4 Receptors and Signal Transduction.
4.8.5 Biological Effects.
4.8.6 Neurological Disorders and Neurodegenerative Diseases.
4.9 Dynorphin.
4.9.1 General Aspects and History.
4.9.2 Localization Within the Central Nervous System.
4.9.3 Biosynthesis and Degradation.
4.9.4 Receptors and Signal Transduction.
4.9.5 Biological Effects.
4.9.6 Neurological Disorders and Neurodegenerative Diseases.
4.10 Eicosanoids and Arachidonic Acid.
4.10.1 General and History Aspects.
4.10.2 Biosynthesis and Degradation.
4.10.3 Receptors and Signal Transduction.
4.10.4 Biological Effects.
4.10.5 Neurological Disorders and Neurodegenerative Diseases.
4.11 Endorphin.
4.11.1 General Aspects and History.
4.11.2 Localization Within the Central Nervous System.
4.11.3 Biosynthesis and Degradation.
4.11.4 Biological Effects.
4.11.5 Neurological Disorders and Neurodegenerative Diseases.
4.12 Enkephalin.
4.12.1 General Aspects and History.
4.12.2 Localization Within the Central Nervous System.
4.12.3 Biosynthesis and Degradation.
4.12.4 Receptors and Signal Transduction.
4.12.5 Biological Effects.
4.12.6 Neurological Disorders and Neurodegenerative Diseases.
4.13 Fibroblast Growth Factors.
4.13.1 General Aspects and History.
4.13.2 Localization Within the Central Nervous System.
4.13.3 Biosynthesis and Degradation.
4.13.4 Receptors and Signal Transduction.
4.13.5 Biological Effects.
4.13.6 Neurological Disorders and Neurodegenerative Diseases.
4.14 Galanin.
4.14.1 General Aspects and History.
4.14.2 Localization Within the Central Nervous System.
4.14.3 Biosynthesis and Degradation.
4.14.4 Receptors and Signal Transduction.
4.14.5 Biological Effects.
4.14.6 Neurological Disorders and Neurodegenerative Diseases.
4.15 Ghrelin.
4.15.1 General Aspects and History.
4.15.2 Localization Within the Central Nervous System.
4.15.3 Biosynthesis and Degradation.
4.15.4 Receptors and Signal Transduction.
4.15.5 Biological Effects.
4.15.6 Neurological Disorders and Neurodegenerative Diseases.
4.16 Gonadotropin-releasing Hormone.
4.16.1 General Aspects and History.
4.16.2 Localization Within the Central Nervous System.
4.16.3 Biosynthesis and Degradation.
4.16.4 Receptors and Signal Transduction.
4.16.5 Biological Effects.
4.16.6 Neurological Disorders and Neurodegenerative Diseases.
4.17 Growth Hormone-releasing Hormone.
4.17.1 General Aspects and History.
4.17.2 Localization Within the Central Nervous System.
4.17.3 Biosynthesis and Degradation.
4.17.4 Receptors and Signal Transduction.
4.17.5 Biological Effects.
4.17.6 Neurological Disorders and Neurodegenerative Diseases.
4.18 Hypocretin (Orexin).
4.18.1 General Aspects and History.
4.18.2 Localization Within the Central Nervous System.
4.18.3 Biosynthesis and Degradation.
4.18.4 Receptors and Signal Transduction.
4.18.5 Biological Effects.
4.18.6 Neurological Disorders and Neurodegenerative Diseases.
4.19 Interleukin.
4.19.1 General Aspects.
4.19.2 Localization Within the Central Nervous System.
4.19.3 Biosynthesis and Degradation.
4.19.4 Receptors and Signal Transduction.
4.19.5 Biological Effects.
4.19.6 Neurological Disorders and Neurodegenerative Diseases.
4.20 Melanin-concentrating Hormone.
4.20.1 General Aspects and History.
4.20.2 Localization Within the Central Nervous System.
4.20.3 Biosynthesis and Degradation.
4.20.4 Receptors and Signal Transduction.
4.20.5 Biological Effects.
4.20.6 Neurological Disorders and Neurodegenerative Diseases.
4.21 Melanocyte-stimulating Hormone.
4.21.1 General Aspects.
4.21.2 Localization Within the Central Nervous System.
4.21.3 Biosynthesis and Degradation.
4.21.4 Receptors and Signal Transduction.
4.21.5 Biological Effects.
4.21.6 Neurological Disorders and Neurodegenerative Diseases.
4.22 Neuropeptide Y.
4.22.1 General Aspects and History.
4.22.2 Localization Within the Central Nervous System.
4.22.3 Biosynthesis and Degradation.
4.22.4 Receptors and Signal Transduction.
4.22.5 Biological Effects.
4.22.6 Neurological Disorders and Neurodegenerative Diseases.
4.23 Neurotensin.
4.23.1 General Aspects and History.
4.23.2 Localization Within the Central Nervous System.
4.23.3 Biosynthesis and Degradation.
4.23.4 Receptors and Signal Transduction.
4.23.5 Biological Effects.
4.23.6 Neurological Disorders and Neurodegenerative Diseases.
4.24 Neurotrophins.
4.24.1 General Aspects and History.
4.24.2 Localization Within the Central Nervous System.
4.24.3 Biosynthesis and Degradation.
4.24.4 Receptors and Signal Transduction.
4.24.5 Biological Effects.
4.24.6 Neurological Disorders and Neurodegenerative Diseases.
4.25 Nitric Oxide and Carbon Monoxide.
4.25.1 General Aspects and History.
4.25.2 Localization Within the Central Nervous System.
4.25.3 Biosynthesis and Degradation.
4.25.4 Receptors and Signal Transduction.
4.25.5 Biological Functions.
4.25.6 Neurological Disorders and Neurodegenerative Diseases.
4.26 Nociceptin (Orphanin FQ).
4.26.1 General Aspects and History.
4.26.2 Localization Within the Central Nervous System.
4.26.3 Biosynthesis and Degradation.
4.26.4 Receptors and Signal Transduction.
4.26.5 Biological Effects.
4.26.6 Neurological Disorders and Neurodegenerative Diseases.
4.27 Pituitary Adenylate Cyclase-activating Polypeptide.
4.27.1 General Aspects and History.
4.27.2 Localization Within the Central Nervous System.
4.27.3 Biosynthesis and Degradation.
4.27.4 Receptors and Signal Transduction.
4.27.5 Biological Effects.
4.27.6 Neurological Disorders and Neurodegenerative Diseases.
4.28 Proopiomelanocortin.
4.28.1 General Aspects and History.
4.28.2 Localization Within the Central Nervous System.
4.28.3 Biosynthesis and Degradation.
4.28.4 Receptors and Signal Transduction.
4.28.5 Biological Effects.
4.29 Purines.
4.29.1 General Aspects.
4.29.2 Biosynthesis and Degradation.
4.29.3 Receptors and Signal Transduction.
4.29.4 Biological Effects.
4.29.5 Neurological Disorders and Neurodegenerative Diseases.
4.30 Somatostatin.
4.30.1 General Aspects and History.
4.30.2 Localization Within the Central Nervous System.
4.30.3 Biosynthesis and Degradation.
4.30.4 Receptors and Signal Transduction.
4.30.5 Biological Effects.
4.30.6 Neurological Disorders and Neurodegenerative Diseases.
4.31 Substance P and Tachykinins.
4.31.1 General Aspects and History.
4.31.2 Localization Within the Central Nervous System.
4.31.3 Biosynthesis and Degradation.
4.31.4 Receptors and Signal Transduction.
4.31.5 Biological Effects.
4.31.6 Neurological Disorders and Neurodegenerative Diseases.
4.32 Thyrotropin-releasing Hormone.
4.32.1 General Aspects and History.
4.32.2 Localization Within the Central Nervous System.
4.32.3 Biosynthesis and Degradation.
4.32.4 Receptors and Signal Transduction.
4.32.5 Biological Effects.
4.32.6 Neurological Disorders and Neurodegenerative Diseases.
4.33 The Tyr-MIF-1 Family.
4.34 Vasoactive Intestinal Polypeptide.
4.34.1 General Aspects and History.
4.34.2 Localization Within the Central Nervous System.
4.34.3 Biosynthesis and Degradation.
4.34.4 Receptors and Signal Transduction.
4.34.5 Biological Effects.
4.34.6 Neurological Disorders and Neurodegenerative Diseases.
4.35 Vasopressin and Oxytocin.
4.35.1 General Aspects and History.
4.35.2 Localization Within the Central Nervous System.
4.35.3 Biosynthesis and Degradation.
4.35.4 Receptors and Signal Transduction.
4.35.5 Biological Effects.
4.35.6 Neurological Disorders and Neurodegenerative Diseases.
4.36 Deorphanized Neuropeptides.
4.36.1 Apelin.
4.36.2 Kisspeptin/Metastin.
4.36.3 Opiod-modulating Peptides (NPFF and NPAF).
A Appendix.
A1 Amino Acids.
A2 Nucleotides.
A3 Abbreviations for Neurotransmitters and Neuromodulators.
A4 Miscellaneous Abbreviations (Enzymes and Transporters).
Subject Index.
http://as.wiley.com/WileyCDA/WileyTitle/productCd-3527313079.html
|
|
|
